Ask AI
ProCE Banner Events

Share

Thursday, January 19, 2023 - State-of-the-Art Care in CLL/SLL: Best Practices in an Expanding Therapeutic Landscape


Pharmacists: 1.00 contact hour (0.1 CEUs)

This event has expired. No longer available for credits.

Credits Available

1.00

Who Should Attend

Join us for this 1-hour webinar with a live Q&A session where experts discuss the latest data on their approaches to caring for patients with CLL/SLL, including information on management of treatment-naive and relapsed/refractory CLL/SLL.

Time and location

Thursday, January 19, 2023

3:00 PM - 4:00 PM Eastern Time (ET)

Virtual

Agenda

  • Welcome and Program Overview
  • Current Treatment Pathways and Consensus Recommendations in CLL/SLL
  • Understanding Available Classes of Therapy and Their Role in Treatment of CLL/SLL
  • Emerging Treatment Strategies for CLL/SLL
  • Role of Pharmacists in Optimizing CLL/SLL Management Through Patient-Centered Care
  • Audience Q&A and Closing Remarks

CME/CE Info

Program Overview
This program presents the latest clinical data to aid pharmacists in providing optimal care for their patients with CLL/SLL, including downloadable slides from the live, 1-hour webinars, and ClinicalThought commentaries with key take-home points and FAQs from the webinars.

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of pharmacists in the management of patients with CLL/SLL.

Target Audience
The target audience is pharmacists, including clinical and health-system, ambulatory care, and community pharmacists, who care for patients with CLL/SLL, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in health-system pharmacy.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply current evidence and guidelines for the treatment and management of treatment-naive and relapsed/refractory CLL/SLL, taking into consideration the agent’s toxicity profile, prognostic variables, comorbidities, and patient preference
  • Foster collaborative discussions between patients, caregivers, and healthcare professionals to guide personalized treatment planning
  • Appraise intraclass differences in selectivity, binding, efficacy, and adverse event profiles among agents used to treat CLL/SLL
  • Evaluate strategies to proactively mitigate and manage treatment-related adverse events that occur with current and emerging approaches

Accreditation

CE Accreditation

Pharmacists

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-23-002-L01-P has been assigned to this live application-based activity (initial release date 01/19/2023). This activity is approved for 1.0 contact hour (0.1 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.proce.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.

Acknowledgement

Provided by ProCE, LLC.

Supported by educational grants from Genentech, a member of the Roche Group and AstraZeneca.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.